Tissue Repair Ltd (ASX:TRP)
Australia · Delayed Price · Currency is AUD 0.2050
-0.1050 (-33.87%)
Jan 30, 2026, 4:10 PM AEST
Tissue Repair Revenue
In the fiscal year ending June 30, 2025, Tissue Repair had annual revenue of 2.63M AUD with 47.04% growth. Tissue Repair had revenue of 1.98M in the half year ending June 30, 2025, with 103.67% growth.
Revenue
2.63M
Revenue Growth
+47.04%
P/S Ratio
4.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 2.63M | 842.43K | 47.04% |
| Jun 30, 2024 | 1.79M | 819.21K | 84.31% |
| Jun 30, 2023 | 971.66K | 799.73K | 465.18% |
| Jun 30, 2022 | 171.92K | 19.29K | 12.63% |
| Jun 30, 2021 | 152.64K | 152.48K | 97,743.59% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chimeric Therapeutics | 12.68M |
| Immuron | 7.29M |
| Argenica Therapeutics | 3.21M |
| Noxopharm | 2.82M |
| Neurotech International | 2.44M |
| Biotron | 1.81M |
| Avecho Biotechnology | 1.38M |
| Patrys | 828.54K |